| Literature DB >> 24995038 |
Angelo G Aulisa1, Marco Giordano1, Francesco Falciglia1, Emanuele Marzetti2, Andrea Poscia3, Vincenzo Guzzanti4.
Abstract
BACKGROUND: Over the last years, evidence has accumulated in support of bracing as an effective treatment option in patients with idiopathic scoliosis. Yet, little information is available on the impact of compliance on the outcome of conservative treatment in scoliotic subjects. The aim of the present study was to prospectively evaluate the association between compliance to brace treatment and the progression of scoliotic curve in patients with idiopathic adolescent (AIS) or juvenile scoliosis (JIS).Entities:
Keywords: Adolescent idiopathic scoliosis; Compliance; Conservative treatment; Juvenile idiopathic scoliosis; PASB brace
Year: 2014 PMID: 24995038 PMCID: PMC4080685 DOI: 10.1186/1748-7161-9-6
Source DB: PubMed Journal: Scoliosis ISSN: 1748-7161
Sample characteristics
| Gender | Male | 116 | 367 |
| Female | 11 | 28 | |
| Curve | Double major | 5 | 11 |
| Lumbar | 24 | 96 | |
| Thoracic | 34 | 77 | |
| Thoracolumbar | 64 | 211 | |
| Brace | Lion | 18 | 138 |
| Milw | 52 | 42 | |
| Pasb | 57 | 215 | |
| Compliance | Complete | 66 | 253 |
| Incomplete A | 12 | 15 | |
| Incomplete B | 25 | 31 | |
| Incomplete C | 14 | 60 | |
| Incomplete D | 10 | 36 | |
| Total (522) | 127 | 395 | |
COBB degrees distribution according the treatment adherence
| mean | 29.4 | 10.9 | −18.5 | Reference | |
| SD | 6.7 | 9.5 | (p < 0.001) | ||
| mean | 29.2 | 21.8 | −7.4 | 11.1 | |
| SD | 6.9 | 9.1 | (P = 0.006) | (p < 0.001) | |
| mean | 29.2 | 24.9 | −4.1 | 14.4 | |
| SD | 6.8 | 10.9 | (p = 0.045) | (p < 0.001) | |
| mean | 28.8 | 18.4 | −10.4 | 8.1 | |
| SD | 8.1 | 5.5 | (p < 0.001) | (p < 0.001) | |
| mean | 32.6 | 24.2 | −8.4 | 10.1 | |
| SD | 7.5 | 6.2 | (p < 0.001) | (p < 0.001) | |
| mean | 29.5 | 16.5 | −13 | | |
| SD | 6.9 | 11.0 | (p < 0.001) | ||
| | |||||
| mean | 30.5 | 13.1 | −17.4 | Reference | |
| SD | 8.0 | 10.0 | (p < 0.001) | ||
| mean | 30.5 | 20.8 | −9.7 | 7.7 | |
| SD | 5.1 | 6.8 | (p < 0.001) | (p < 0.001) | |
| mean | 28.6 | 24.2 | −4.4 | 13 | |
| SD | 7.0 | 8.0 | (p = ns) | (p < 0.001) | |
| mean | 30.2 | 20.1 | −10.1 | 7.3 | |
| SD | 6.7 | 7.5 | (p < 0.001) | (p < 0.001) | |
| mean | 31.5 | 23.1 | −8.4 | 9 | |
| SD | 8.8 | 9.0 | (p < 0.001) | (p < 0.001) | |
| mean | 30.4 | 16.3 | −14.1 | ||
| SD | 7.7 | 10.2 | (p < 0.001) | ||
Perdriolle degrees distribution according the treatment adherence
| mean | 12.2 | 6.0 | −6.2 | Reference | |
| SD | 4.1 | 5.6 | (p < 0.001) | ||
| mean | 13.0 | 10.3 | −2.7 | 3.5 | |
| SD | 5.0 | 5.7 | (p = 0.049) | (p = 0.013) | |
| mean | 14.1 | 12.5 | −1.6 | 4.6 | |
| SD | 4.7 | 6.1 | (p = 0.199) | (p < 0.001) | |
| mean | 10.2 | 8.5 | −1.7 | 4.5 | |
| SD | 2.8 | 2.3 | (p = 0.143) | (p = 0.001) | |
| mean | 14.6 | 14.3 | −0.3 | 5.9 | |
| SD | 5.4 | 5.2 | (p = 0.766) | (p < 0.001) | |
| mean | 12.9 | 8.7 | −4.2 | | |
| SD | 4.9 | 6.2 | (p < 0.001) | ||
| | |||||
| mean | 12.0 | 6.2 | −5.8 | Reference | |
| SD | 4.1 | 5.2 | (p < 0.001) | ||
| mean | 14.9 | 11.2 | −3.7 | 2.1 | |
| SD | 4.7 | 6.6 | (p < 0.001) | (p < 0.001) | |
| mean | 12.9 | 11.4 | −1.5 | 4.3 | |
| SD | 4.1 | 5.6 | (p < 0.09) | (p < 0.001) | |
| mean | 14.4 | 10.9 | −3.5 | 2.3 | |
| SD | 4.9 | 5.9 | (p < 0.001) | (p < 0.001) | |
| mean | 13.7 | 10.9 | −2.8 | 3.0 | |
| SD | 5.9 | 20.0 | (p < 0.001) | (p < 0.001) | |
| mean | 12.8 | 8.3 | −4.5 | ||
| SD | 4.6 | 8.3 | (p < 0.001) | ||
Figure 1Difference between t5 and t1 in Cobb degree (blue boxes) and Perdriolle degree (red boxes) over type of scoliosis and Compliance (0 = complete; 1 = brace removed for 1 month of a year (incomplete A); 2 = brace removed for 2 months of a year (incomplete B); 3 = brace removed during school hours (incomplete C); 4 = Incomplete D).
Multiple linear regression: results for Cobb degree difference (t5 vs baseline)
| Adherence | Complete (reference) | - | - | - | - | - | - |
| Incomplete A | 8.57 | 2.36 | 0.000 | 6.54 | 1.49 | 0.000 | |
| Incomplete B | 13.77 | 1.78 | 0.000 | 11.39 | 1.08 | 0.000 | |
| Incomplete C | 7.30 | 2.43 | 0.003 | 6.88 | 0.83 | 0.000 | |
| Incomplete D | 10.35 | 2.53 | 0.000 | 8.60 | 1.02 | 0.000 | |
| Gender | 4.02 | 2.53 | 0.114 | 0.85 | 1.11 | 0.444 | |
| Age baseline | 0.99 | 0.61 | 0.109 | 0.87 | 0.25 | 0.001 | |
| Length of treatment | 0.08 | 0.03 | 0.008 | 0.11 | 0.02 | 0.000 | |
| Cobb at baseline | −0.11 | 0.11 | 0.321 | −0.14 | 0.04 | 0.001 | |
| Type of brace | Lyon (Reference) | - | - | - | - | - | - |
| Milwaukee | 0.76 | 2.14 | 0.724 | −0.29 | 1.01 | 0.776 | |
| Pasb | −1.76 | 2.21 | 0.428 | −2.61 | 0.65 | 0.000 | |
Multiple linear regression: results for Perdriolle degree difference (t5 vs baseline)
| | Complete (reference) | - | - | - | - | - |
| Adherence | Incomplete A | 1.92 | 1.19 | 0.109 | 1.35 | 0.78 |
| Incomplete B | 4.23 | 0.89 | 0.000 | 3.97 | 0.56 | |
| Incomplete C | 3.35 | 1.22 | 0.007 | 1.94 | 0.44 | |
| Incomplete D | 4.65 | 1.27 | 0.000 | 2.46 | 0.54 | |
| Gender | 2.15 | 1.29 | 0.099 | 0.18 | 0.58 | |
| Age baseline | 0.18 | 0.31 | 0.558 | 0.09 | 0.13 | |
| Length of treatment | 0.05 | 0.01 | 0.001 | 0.05 | 0.01 | |
| Perdriolle at baseline | −0.04 | 0.08 | 0.633 | -0.02 | 0.04 | |
| Type of brace | Lyon (Reference) | - | - | - | - | - |
| Milwaukee | −0.18 | 1.08 | 0.865 | 0.21 | 0.52 | |
| Pasb | −0.47 | 1.09 | 0.669 | −0.93 | 0.34 | |
Figure 2Changes in Cobb degrees for each level of compliance during each time point.
Figure 3Changes in Perdriolle degrees for each level of compliance during each time point.
Sample of patients that abandon the treatment
| Risser 0 | 1/55 (1,9%) | 2/65 (1,5%) |
| Risser 1 | 3/55 (5,4%) | 1/65 (3%) |
| Risser 2 | 12/55 (21,8%) | 8/65 (12,5%) |
| Risser 3 | 37/55 (67,2%) | 40/65 (61,5%) |
| Risser 4 | 2/55 (3,6%) | 14/65 (21,5%) |
| Curve correction at time of abandon | 38/55(69,1%) | 55/65 (84,6%) |
| Curve stabilization at time of abandon | 15/55 (27,3%) | 4/65 (6,1%) |
| Curve progression at time of abandon | 2/55 (3,6%) | 6/65 (9,3%) |
| Curve correction at follow-up | - | 19/65 (29,2%) |
| Curve stabilization at follow-up | - | 30/65 (46,2%) |
| Curve progression at follow-up | - | 16/65 (24,6%) |
| Indication to surgery | 55/55 (100%) | 9/65 (13,8%) |